Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,769 shares of the technology company’s stock after purchasing an additional 2,000 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Veeva Systems were worth $8,992,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. Howard Capital Management Inc. grew its position in Veeva Systems by 7.5% in the fourth quarter. Howard Capital Management Inc. now owns 1,177 shares of the technology company’s stock worth $247,000 after acquiring an additional 82 shares in the last quarter. Turning Point Benefit Group Inc. purchased a new position in Veeva Systems in the fourth quarter worth about $393,000. Allianz Asset Management GmbH grew its position in Veeva Systems by 31.9% in the fourth quarter. Allianz Asset Management GmbH now owns 548,493 shares of the technology company’s stock worth $115,321,000 after acquiring an additional 132,633 shares in the last quarter. Centricity Wealth Management LLC purchased a new position in Veeva Systems in the fourth quarter worth about $25,000. Finally, Suncoast Equity Management grew its position in Veeva Systems by 8.9% in the fourth quarter. Suncoast Equity Management now owns 3,715 shares of the technology company’s stock worth $781,000 after acquiring an additional 305 shares in the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Down 1.2 %
Shares of NYSE:VEEV opened at $226.10 on Monday. The company has a market capitalization of $36.71 billion, a price-to-earnings ratio of 55.83, a price-to-earnings-growth ratio of 1.89 and a beta of 0.85. Veeva Systems Inc. has a 52 week low of $170.25 and a 52 week high of $258.93. The firm has a 50 day moving average of $223.76 and a 200 day moving average of $217.86.
Insider Buying and Selling
Wall Street Analyst Weigh In
Several research analysts recently commented on the company. Bank of America lifted their price target on Veeva Systems from $280.00 to $290.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Citigroup boosted their target price on Veeva Systems from $281.00 to $307.00 and gave the company a “buy” rating in a research report on Monday, December 9th. KeyCorp dropped their target price on Veeva Systems from $285.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and set a $270.00 target price on shares of Veeva Systems in a research report on Friday, January 17th. Finally, JPMorgan Chase & Co. boosted their target price on Veeva Systems from $208.00 to $218.00 and gave the company a “neutral” rating in a research report on Monday, December 16th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat.com, Veeva Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $255.08.
Check Out Our Latest Analysis on Veeva Systems
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- How Investors Can Find the Best Cheap Dividend Stocks
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- When to Sell a Stock for Profit or Loss
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 3 Ways To Invest In Coffee, Other Than Drinking It
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.